The histological appearance of rheumatoid synovial membrane suggests that the cellular immune response might be important in the pathogenesis of the disease. Consequently there have been a number of studies on the cytotoxic potential of lymphocytes from patients with rheumatoid arthritis (RA) towards a variety of target cells-for example, human fetal fibroblasts,1-3 Chang human liver cells,4 and allogeneic or autologous synovial cells. [5] [6] [7] The investigation of Griffiths et al.7 is of particular interest because, although largely a study of allogeneic lymphocytes and target cells, it included a limited sample of cytotoxicity assays of an entirely autologous nature. These results argued against the presence of synovial cell neoantigens inducing specific immunological attack by sensitised lymphocytes.
The present study examined a larger sample of cultures of rheumatoid synovial membrane cells by 2 different cytotoxic assay systems for evidence of cytotoxicity by autologous peripheral blood lymphocytes. In an attempt to 'damp down' the potentially cytotoxic effect of activated synovial macrophages during the first few days of the synovial cells in culture some cultures were established in the presence of hydrocortisone.8
Accepted for publication 16 Cell-mediated cytotoxicity assessed by microcytotoxicity assay (MA) test system. Sterile, disposable microtest tissue culture plates (Terasaki plates; Nunc) were used. These microtest plates contain 60 flat-bottomed wells, each with a capacity of 15-20~tl Synovial membrane fibroblasts were established in culture in TCM, TCM with added hydrocortisone (TCM-HC), and in TCM after 1 cycle of rapid freezing in liquid nitrogen followed by thawing at 370C (Nit). Target cells were added to 20 wells of a Terasaki plate to give 50-100 adherent cells per well after 2 hours incubation at 370C. Autologous peripheral blood lymphocytes (2-5 x 103 -5 x 103 per well) were added to 10 wells and TCM to the 10 control wells. Plates were incubated for 24 hours, washed with PBS fixed in methanol, and stained by Giesma solution. The number of remaining target cells per well were counted, and the difference between the mean obtained in the control row compared with that of the test row by Student's I test.
Discussion
In experiments involving either murine tumour cells or virus-infected target cells mixed with thymus-derived T-lymphocytes clear evidence has been obtained that there is a cellular immune response and that the effector or cytotoxic cell involved is the T cell. T-cell-mediated cytotoxicity of virusinfected or hapten-modified target cells in mice is restricted by the H-2D and H-2K antigens of the major histocompatibility complex (MHC). Cytotoxic T cells are therefore active only against target cells sharing these antigens with the animal in which the cytotoxic cells have been raised.10 11 There is also evidence to suggest that a similar MHC restriction might operate within the human HLA system.12 13 For T cell cytotoxicity to be expressed in neoantigenbearing synovial cells effector cells would be required to share some important HLA antigens with target cells in addition to being sensitised to the neoantigen. Allogeneic cytotoxic systems using synovial cells and T cells would therefore be unlikely to reveal specific cytotoxicity, even if the target cell was expressing antigens against which the donor lymphocytes were sensitised. Only an entirely autologous test system would reveal T cell cytotoxicity.
In the present study synovial membranes cells from 25 patients with RA were tested in a chromium release assay (CRT) 
